The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Part of the problem with the effect of peptides is many people take them and levels that are far above the physiologic range. Even individuals who are checking their IGF-1 while they take these different GHRPs, most of them do not check the binding peptides-- for example, IGF binding peptide 1, 2, or 3. And their free IGF-1 level might be significantly different.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.